Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance.
Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance. — المؤلف: Xu, Haiyan — Thoracic cancer 20200630
- المؤلف
- Xu, Haiyan
- النشر
- Thoracic cancer 20200630
- الوصف
- 1096-1102 p.
- الموضوعات
- Adult؛ Aged؛ Anaplastic Lymphoma Kinase؛ Antineoplastic Agents؛ Carcinoma, Non-Small-Cell Lung؛ Crizotinib؛ Disease Progression؛ Drug Resistance, Neoplasm